Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
Study NCT ID:
NCT05544916
Status:
COMPLETED
Last Update Posted:
2023-10-10
First Post:
2022-09-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections
Sponsor:
Valenta Pharm JSC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-04
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-14
First Submit QC Date:
None
Study First Post Date:
2022-09-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-09
Last Update Post Date:
2023-10-10
Last Update Post Date Type:
ACTUAL